Skip to content

H.R. 7970 · 119th Congress (2025–2027)

STOP Nitazenes Act

This bill permanently places nitazenes as a class into schedule I of the Controlled Substances Act. Nitazenes are synthetic opioids similar to fentanyl that can be as potent or more potent than fentanyl. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

Show official title

To amend the Controlled Substances Act to permanently schedule 2-benzylbenzimidazole opioids (commonly referred to as nitazenes) as Schedule 1 controlled substances, and for other purposes.

Ordered to be reported

Latest actionOrdered reported

This bill’s path

This is H.R. 7970’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Robert E. Latta (R-OH-5)
Cosponsors
10 cosponsors

0 original · 10 later

9 R · 1 D

  1. Rep. Eugene Simon Vindman (D-VA-7)· Later · Mar 26, 2026
  2. Rep. Michael Baumgartner (R-WA-5)· Later · Mar 27, 2026
  3. Rep. David P. Joyce (R-OH-14)· Later · Mar 27, 2026
  4. Rep. Tracey Mann (R-KS-1)· Later · Apr 9, 2026
  5. Rep. James R. Baird (R-IN-4)· Later · Apr 27, 2026
  6. Rep. August Pfluger (R-TX-11)· Later · Apr 27, 2026
  7. Rep. Addison P. McDowell (R-NC-6)· Later · May 13, 2026
  8. Rep. Craig A. Goldman (R-TX-12)· Later · Jun 30, 2026
  9. Rep. Tim Moore (R-NC-14)· Later · Jul 13, 2026
  10. Rep. Ken Calvert (R-CA-41)· Later · Jul 22, 2026
Policy area
Crime and Law Enforcement
Subjects
  • Administrative law and regulatory procedures
  • Department of Justice
  • Drug trafficking and controlled substances

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Referred to Health

    Referred to the Subcommittee on Health.

    Sources
  2. Introduced in House

    Document: Introduced in House

    Sources
  3. Latest
    ▸ 6 committee actions · Mar 18, 2026 – Jul 21, 2026
    1. Referred to committee

      Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

      Sources
    2. Subcommittee markup session held

      Subcommittee Consideration and Mark-up Session Held

      Sources
    3. Forwarded by subcommittee

      Forwarded by Subcommittee to Full Committee by Voice Vote.

      Sources
    4. Markup session held

      Committee Consideration and Mark-up Session Held

      Sources
    5. Markup session held

      Committee Consideration and Mark-up Session Held

      Sources
    6. Ordered reported

      Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 21.

      Sources

Committees

  1. HouseEnergy and CommerceReferred Mar 18, 2026 · Markup Jul 20, 2026 · Markup Jul 21, 2026
    1. Jul 20, 2026 · Markup

    2. Jul 1, 2026 · Markup

  2. HouseHealthReferred Mar 18, 2026 · Markup Jun 25, 2026 · Reported Jun 25, 2026
    1. Jun 25, 2026 · Markup

    2. Mar 26, 2026 · Hearing

  3. HouseJudiciaryReferred Mar 18, 2026

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (3)
  1. STOP Nitazenes Act

    Display title, Short title · Introduced in House

  2. Strengthening Tools to Outlaw Poisonous Nitazenes Act

    Short title · Introduced in House

  3. To amend the Controlled Substances Act to permanently schedule 2-benzylbenzimidazole opioids (commonly referred to as nitazenes) as Schedule 1 controlled substances, and for other purposes.

    Official title · Introduced in House